- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Anxiety In Major Depressive Disorder

Virtual Event – Anxiety In Major Depressive Disorder
Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.
Featuring
-
Chet Robachinski, MD
Psychiatric Director, Bailey-Boushay House, Seattle, WA; Founding Partner, Associates in Behavioral Health
-
Simon Kim, PharmD
Medical Science Liaison
Chet Robachinski is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Simon Kim is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Register
This event registration is closed.